Other forms of aspergillosis
ICD-10 B44.89 is a billable code used to indicate a diagnosis of other forms of aspergillosis.
Aspergillosis is a fungal infection caused by the Aspergillus species, which are ubiquitous in the environment. While the most common form is allergic bronchopulmonary aspergillosis (ABPA), other forms include invasive aspergillosis, chronic pulmonary aspergillosis, and aspergilloma. Patients with compromised immune systems, such as those undergoing chemotherapy, organ transplant recipients, or individuals with HIV/AIDS, are particularly susceptible to invasive forms of the disease. Symptoms can range from mild respiratory issues to severe systemic infections, depending on the patient's immune status and the form of aspergillosis. Diagnosis typically involves imaging studies, such as CT scans, and microbiological cultures. Treatment often includes antifungal medications such as voriconazole or amphotericin B, and in some cases, surgical intervention may be necessary to remove infected tissue. The complexity of managing aspergillosis lies in the variability of clinical presentations and the need for tailored antifungal therapy, especially in immunocompromised patients.
Detailed clinical notes on the patient's immune status, diagnostic tests performed, and treatment plans.
Patients presenting with respiratory symptoms and a history of immunosuppression.
Ensure that all forms of aspergillosis are documented, including any complications.
Pulmonary function tests, imaging results, and treatment response notes.
Patients with chronic cough, hemoptysis, or lung nodules.
Document the patient's history of lung disease and any prior treatments.
Used when a fungal infection is suspected and cultures are taken.
Document the source of the culture and clinical indications for testing.
Infectious disease specialists should ensure that the culture results are linked to the diagnosis.
Common symptoms include cough, fever, chest pain, and difficulty breathing. In immunocompromised patients, symptoms can be more severe and systemic.
Diagnosis typically involves imaging studies, such as CT scans, and microbiological cultures to confirm the presence of Aspergillus species.
Treatment options include antifungal medications such as voriconazole, amphotericin B, and in some cases, surgical intervention to remove infected tissue.
